Skip to Content

M P4 (Paroxetine Hydrochloride Extended-Release 25 mg)

Pill with imprint M P4 is Purple, Round and has been identified as Paroxetine Hydrochloride Extended-Release 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; postmenopausal symptoms; body dysmorphic disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M P4

Paroxetine hydrochloride extended-release 25 mg M P4
Paroxetine hydrochloride extended-release 25 mg M P4  Front
Paroxetine hydrochloride extended-release 25 mg M P4  Back
Paroxetine hydrochloride extended-release 25 mg M P4  Front
Paroxetine hydrochloride extended-release 25 mg M P4  Back
Paroxetine hydrochloride extended-release 25 mg M P4
Paroxetine hydrochloride extended-release 25 mg M P4

Paroxetine Hydrochloride Extended-Release

Imprint:
M P4
Strength:
25 mg
Color:
Purple
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Selective serotonin reuptake inhibitors
Pregnancy Category:
D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
ferrosoferric oxide
silicon dioxide
D&C Red No. 30
FD&C Blue No. 2
FD&C Yellow No. 6
hydroxypropyl cellulose (type h)
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polydextrose
polyethylene glycol
polysorbate 80
propylene glycol
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0825 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide